We would like to thank Roche for supporting the Poster Area

.

SELECTED ABSTRACTS FOR POSTER PRESENTATIONS IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST AUTHOR

Abstract # Abstract Title and Presenting Author
1 A CASE OF MYELOMATOUS MENINGITIS
Katrin Alizadeh, UK
View ePoster
2 AL-Amyloïdosis, a rare and challenging complication of Waldenström macroglobulinemia
Sarah Bailly, Belgium
View ePoster
3 ANTI-ANGIOGENIC EFFECT OF BORTEZOMIB IN MULTIPLE MYELOMA IS ASSOCIATED WITH LOWER NF-kB EXPRESSION
Dragana Grohovac, Croatia
View ePoster
4 ASSOCIATION BETWEEN MULTIPLE MYELOMA DEATHS AND EDUCATIONAL LEVELS IN BRAZIL
Ricardo José Razera, Brazil
View ePoster | Watch Video
5 BORTEZOMIB ACTIVATION OF mTORC1 IMPAIRS AUTOPHAGIC FLUX RESULTING IN DRG CELL DAMAGE
Bing Chen, China
View ePoster | Watch Video
6 BULLOUS DERMATOSIS AS FIRST MANIFESTATION OF IgA MULTIPLE MYLOMA
Ines Dufour, Belgium
View ePoster
7 CENTRAL NERVOUS SYSTEM MYELOMA TREATED WITH VENETOCLAX: A CASE REPORT
Virág Réka Szita, Hungary
View ePoster | Watch Video
8 Chronic neutrophilic leukemia, a rare and challenging diagnosis when associated to myeloma
Joséphine Mennig, France
View ePoster
9 Clinical case – PET/CT role in a MM patient presenting with a skull plasmacytoma
Joana Santos, Portugal
View ePoster
10 COLON PERFORATION IN MULTIPLE MYELOMA PATIENTS – A COMPLICATION OF HIGH-DOSE STEROID TREATMENT
Iuliana Vaxman, USA
View ePoster
11 DARATUMUMAB TREATMENT IN HEAVELY PRE-TREATED IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS
Fabio Andreozzi, Belgium
View ePoster
12 DEATHS BY MULTIPLE MYELOMA AND MALIGNANT PLASMA CELL NEOPLASMS IN BRAZIL FROM 2014 TO 2018
Raissa Silva Frota, Brazil
View ePoster | Watch Video
13 DREAMM-2: Belantamab Mafodotin (Belamaf) in Patients with Multiple Myeloma Refractory to Proteasome Inhibitors, Immunomodulatory Agents, and Refractory/Intolerant to Anti-CD38 mAb, Including Subgroups with Renal Impairment (RI) and High-Risk (HR) Cytogenetics
Loniel Sagar, USA
View ePoster
14 EPIDEMIOLOGY OF MULTIPLE MYELOMA AT AMAZONIA: ARE THERE ANY PARTICULARITIES?
João Pedro dos Santos Bentes, Brazil
View ePoster | Watch Video
15 EXTRAMEDULLARY PLASMACYTOMA MIMICKING KLATSKIN TUMOR
Ines Dufour, Belgium
View ePoster
16 HIGH-DOSE CHEMOTHERAPY FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA IN THE REAL WORLD SETTING. SINGLE-CENTER EXPERIENCE
Nikita Mochkin, Russia
View ePoster | Watch Video
17 HORIZON (OP-106): An exploratory analysis of time-to-next treatment (TTNT) in patients with relapsed/refractory multiple myeloma (RRMM) who received melflufen plus dexamethasone
Maria-Victoria Mateos, Spain
View ePoster | Watch Video
18 HOW DOES COVID-19 PANDEMIC AFFECT BELGIAN MYELOMA PATIENTS?
Marie-Christiane Vekemans, Belgium
View ePoster
19 IGM RELATED AL AMYLOIDOSIS: ABOUT 2 CASES
Marie-Christiane Vekemans, Belgium
View ePoster
20 INCREASE IN THE NUMBER OF CASES OF MULTIPLE MYELOMA AMONG RESIDENTS OF THE STATE OF AMAZONAS, BRAZIL AND ITS CONDITIONS OF ACCESS TO HEALTH SERVICES
Raphael Maia Oliveira, Brazil
View ePoster | Watch Video
21 LIFE THREATENING GASTROINTESTINAL BLEEDING DUE TO COLONIC PLASMACYTOMAS IN A HEAVILY PRETREATED YOUNG MYELOMA PATIENT
Omur Gokmen Sevindik, Turkey
View ePoster
22 LONG-TERM PROTEASOME INHIBITOR (PI)-BASED THERAPY IN MULTIPLE MYELOMA (MM) FOLLOWING IN-CLASS TRANSITION (ICT) FROM PARENTERAL BORTEZOMIB-BASED INDUCTION TO ALL-ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): ANALYSIS OF THE COMMUNITY-BASED US MM-6 STUDY BY AGE
Ruemu E. Birhiray, USA
View ePoster | Watch Video
23 MORTALITY ARISING FROM MULTIPLE MYELOMA IN THE SEVERAL REGIONS OF BRAZIL FROM 2014 TO 2018 ACCORDING TO DATASUS
Talita Costa Barbosa, Brazil
View ePoster
24 MULTIPLE MYELOMA IN THE ELDERLY: AN IRISH PERSPECTIVE
Bronwyn Cummings, Ireland
View ePoster
25 MULTIPLE MYELOMA PRESENTING WITH MULTIPLE CRANIAL NERVES PALSY
Pedro Monteiro, Portugal
View ePoster | Watch Video
26 MYELOMA CAST NEPHROPATHY LEADING TO EARLY KIDNEY ALLOGRAFT DYSFUNCTION: A CASE REPORT
Marie-Christiane Vekemans, Belgium
View ePoster
27 ORTHOPEDIC TREATMENT OF MULTIPLE MYELOMA: SISTEMATIC REVIEW
Talita de Oliveira Felippe, Brazil
View ePoster | Watch Video
28 PATIENT PREFERENCES, TREATMENT SATISFACTION, AND QUALITY OF LIFE (QOL) IN NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (RR) MULTIPLE MYELOMA (MM) PATIENTS RECEIVING INJECTABLE-CONTAINING OR FULLY ORAL THERAPIES: THE EASEMENT STUDY
Neil Rabin, UK
View ePoster | Watch Video
29 SEROLOGIC TESTING FOR SARS-CoV-2 IN MULTIPLE MYELOMA
Virág Réka Szita, Hungary
View ePoster | Watch Video
30 SEVERE DYSAUTONOMY REVEALING AL AMYLOIDOSIS WITH MULTIPLE ORGAN INVOLVEMENT
Laurence Bamps, Belgium
View ePoster | Watch Video
31 Successful Autologous Stem Cell Transplantation for POEMS Syndrome
Ali Ünal, Turkey
View ePoster
32 SURVIVAL OF MULTIPLE MYELOMA PATIENTS RELATED TO RDW
Lila Seraj, Albania
View ePoster
33 T-CELLS FUNCTIONAL REGENERATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION
Keranka Dimitrova, Bulgaria
View ePoster
34 The Effect of Adding Pharmacologic Dose Ascorbic Acid to Carfilzomib, Lenalidomide, Dexamethasone Regimen in Patients with Relapsed/Refractory Multiple Myeloma
Atakan Turgutkaya, Turkey
View ePoster
35 THE IMPORTANCE OF A CORRECT DIAGNOSIS BETWEEN MGUS AND SMOLDERING MULTIPLE MYELOMA
Guilherme Knebel, Brazil
View ePoster | Watch Video
36 THE USE OF IMMUNOMODULATORY DRUGS FOR RECURRENT MULTIPLE MYELOMA: BRAZIL IN CONTRAST WITH THE WORLD
Vanessa Nicola Lebrea, Brazil
View ePoster | Watch Video
37 TREATMENT PROFILE OF MULTIPLE MYELOMA AT AMAZONIA (NORTHERN STATES OF BRAZIL): WHAT IS SPECIAL?
João Pedro Santos Bentes, Brazil
View ePoster | Watch Video
38 WALDENSTROM MACROGLOBULINEMIA: THE CHALLENGE OF DIAGNOSIS IN PUBLIC HEALTHCARE SYSTEM IN BRAZIL
Isabela Paulino Serur, Brazil
View ePoster | Watch Video

SELECTED ABSTRACTS FOR POSTER PRESENTATIONS IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST AUTHOR